Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11721857 | 0.74 | ALDH1A1 (0.53) | ALDH1A1KDM4EMAPTPOLBL3MBTL1 | |
| SCHEMBL7028443 | 0.71 | KDM4E (0.33) | ALDH1A1KDM4EMAPTGAALMNA | |
| SCHEMBL7023893 | 0.71 | POLB (0.34) | POLBGAA | |
| SCHEMBL10599397 | 0.71 | POLB (0.65) | ALDH1A1KDM4EMAPTPOLBHTT | |
| Hydrochloric Acid SCHEMBL7029949 | 0.70 | POLB (0.33) | POLBGAA | |
| Hydrochloric Acid SCHEMBL7031307 | 0.70 | GAA (0.33) | ALDH1A1KDM4EMAPTGAA | |
| Hydrochloric Acid SCHEMBL7023278 | 0.70 | ALDH1A1 (0.96) | ALDH1A1KDM4EMAPTPOLBL3MBTL1 | |
| SCHEMBL10833000 | 0.70 | KDM4E (0.35) | ALDH1A1KDM4EMAPTPOLBRAB9A | |
| SCHEMBL373770 | 0.69 | — | — | |
| SCHEMBL7144640 | 0.67 | ALDH1A1 (0.33) | ALDH1A1KDM4EMAPTPOLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0889884-B1 | 1,2,4-TRIAZINE DERIVATIVES FOR THE INHIBITION OF PROTEIN GLYCOSYLATION | ALTEON INC (US) | 2003-01-29 | — | — | EP | claimed |
| US-6380192-B1 | FOR INHIBITING NONENZYMATIC CROSS-LINKING (PROTEIN AGING) | ALTEON, INC. | 2002-04-30 | — | — | US | claimed |
| US-5932578-A | CAPABLE OF INHIBITING THE FORMATION OF ADVANCED GLYCOSYLATION ENDPRODUCTS OF TARGET PROTEINS. FOOD SPOILAGE AND ANIMAL PROTEIN AGING CAN BE TREATED. | ALTEON INC. (US) | 1999-08-03 | — | — | US | claimed |
| EP-0889884-A1 | 1,2,4-TRIAZINE DERIVATIVES FOR THE INHIBITION OF PROTEIN GLYCOSYLATION | ALTEON, INC. (US) | 1999-01-13 | — | — | EP | claimed |
| WO-1997035849-A1 | 1,2,4-TRIAZINE DERIVATIVES FOR THE INHIBITION OF PROTEIN GLYCOSYLATION | ALTEON INC. (US) | 1997-10-02 | — | — | WO | claimed |
| EP-0889884-B1 | 1,2,4-TRIAZINE DERIVATIVES FOR THE INHIBITION OF PROTEIN GLYCOSYLATION | ALTEON INC (US) | 2003-01-29 | — | — | EP | disclosed |
| US-6380192-B1 | FOR INHIBITING NONENZYMATIC CROSS-LINKING (PROTEIN AGING) | ALTEON, INC. | 2002-04-30 | — | — | US | disclosed |
| US-6060470-A | Triazine compounds and methods of use therefor | ALTEON, INC. | 2000-05-09 | — | — | US | disclosed |
| US-5932578-A | CAPABLE OF INHIBITING THE FORMATION OF ADVANCED GLYCOSYLATION ENDPRODUCTS OF TARGET PROTEINS. FOOD SPOILAGE AND ANIMAL PROTEIN AGING CAN BE TREATED. | ALTEON INC. (US) | 1999-08-03 | — | — | US | disclosed |
| EP-0889884-A1 | 1,2,4-TRIAZINE DERIVATIVES FOR THE INHIBITION OF PROTEIN GLYCOSYLATION | ALTEON, INC. (US) | 1999-01-13 | — | — | EP | disclosed |
| WO-1997035849-A1 | 1,2,4-TRIAZINE DERIVATIVES FOR THE INHIBITION OF PROTEIN GLYCOSYLATION | ALTEON INC. (US) | 1997-10-02 | — | — | WO | disclosed |